Show simple item record

Efectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34

dc.creatorCalvo A.,Mario
dc.date2004-12-01
dc.date.accessioned2020-02-17T15:34:42Z
dc.date.available2020-02-17T15:34:42Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-10182004000400013
dc.identifier.urihttps://revistaschilenas.uchile.cl/handle/2250/131474
dc.formattext/html
dc.languagees
dc.publisherSociedad Chilena de Infectología
dc.relation10.4067/S0716-10182004000400013
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceRevista chilena de infectología v.21 n.4 2004
dc.titleEfectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Laurent C, Kovanfack C, Koulla-Shiro S, Nikové N et al. Lancet 2004; 364: 29-34


This item appears in the following Collection(s)

Show simple item record